Furthermore, CD47 and PD-L1 bispecific antibody (6MW3211) was found to exhibit lower toxicity reactions and synergistic anti-tumor effects via increasing IFN-γ levels and promoting phagocytosis of macrophages 160. This evidence concerns the gene CD47 and neoplasm.